Postibrutinib relapse outcomes for patients with marginal zone lymphoma

Affiliations

• ¹ Division of Hematology, The Ohio State University, Columbus, OH.
• ² Division of Hematology, Washington University, St. Louis, MO.
• ³ Levine Cancer Center, Atrium Health, Charlotte, NC.
• ⁴ Vanderbilt University Medical Center, Nashville, TN.
• ⁵ Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC.
• ⁶ Division of Hematology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
• ⁷ Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
• ⁸ Division of Hematology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI.
• ⁹ Division of Hematology and Oncology, University of Vermont, Burlington, VT.
• ¹⁰ Division of Hematology, Thomas Jefferson University, Philadelphia, PA.
• ¹¹ Winship Cancer Institute, Emory University Medical Center, Atlanta, GA.
• ¹² Division of Hematology, Brown University, Providence, RI.
• ¹³ Division of Hematology, University of Wisconsin, Madison, WI.
• ¹⁴ Cancer Institute of New Jersey, New Brunswick, NJ.
• ¹⁵ Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC.
• ¹⁶ Division of Hematology, University of Minnesota, Minneapolis, MN.
• ¹⁷ University Hospitals Seidman Cancer Center, Cleveland, OH.
• ¹⁸ Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY.
• ¹⁹ Division of Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
• ²⁰ Division of Hematology and Oncology, University of Iowa, Iowa City, IA.
• ²¹ Division of Hematology, Northwestern University, Chicago, IL.
• ²² Division of Hematology and Oncology, Rush University, Chicago, IL.
• ²³ Division of Hematology, Yale University, New Haven, CT.
• ²⁴ Division of Hematology, University of Miami, Miami, FL.
• ²⁵ Division of Hematology, City of Hope, Duarte, CA.